Regulation by DDAH/ADMA pathway of lipopolysaccharide-induced tissue factor expression in endothelial cells

Thrombosis and Haemostasis

Volumn 97, Issue 5, 2007, Pages 830-838

  Xin, Hong Ya ^a   Jiang, De Jian ^b   Jia, Su Jie ^b   Song, Kui ^a   Wang, Guang Ping ^a   Li, Yuan Jian ^b   Chen, Fang Ping ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Asymmetric dimethylarginine; Dimethylarginine dimethylaminohydrolase; Endothelial cells; Lipopolysaccharide; Nuclear factor B; Tissue factor

Indexed keywords

ARGININE; DIMETHYLARGININASE; DIMETHYLARGININASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; THROMBOPLASTIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; UMBILICAL VEIN;

AMIDOHYDROLASES; ARGININE; BASE SEQUENCE; CELLS, CULTURED; DNA PRIMERS; ENDOTHELIAL CELLS; GENE EXPRESSION; HUMANS; LIPOPOLYSACCHARIDES; NF-KAPPA B; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; THROMBOPLASTIN;

EID: 34249027913     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH06-11-0656     Document Type: Article

References (36)

1. ten Cate H. Pathophysiology of disseminated intravascular coagulation in sepsis. Crit Care Med 2000; 28 (9 Suppl): S9-11.
2. Levi M, ten Cate H, Bauer KA, et al. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest 1994; 93: 114-120.
3. Taylor FB Jr, Chang A, Ruf W, et al. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock 1991; 33: 127-134.
4. Warr TA, Rao LV, Rapaport SI. Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: Effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity. Blood 1990; 75: 1481-1489.
5. Crossman DC, Carr DP, Tuddenham EG, et al. The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester. J Biol Chem 1990; 265: 9782-9787.
6. Steffel J, Hermann M, Greutert H, et al. Celecoxib decreases endothelial tissue factor expression through inhibition of c-Jun terminal NH2 kinase phosphorylation. Circulation 2005; 111: 1685-1689.
7. Walford G, Loscalzo J. Nitric oxide in vascular biology. J Thromb Haemost 2003; 1: 2112-2118.
8. Thiemermann C. Nitric oxide and septic shock. Gen Pharmacol 1997; 29: 159-166.
9. Yang Y, Loscalzo J. Regulation of tissue factor expression in human microvascular endothelial cells by nitric oxide. Circulation 2000; 101: 2144-2148.
10. Perez-Ruiz A, Montes R, Velasco F, et al. Regulation by nitric oxide of endotoxin-induced tissue factor and plasminogen activator inhibitor-1 in endothelial cells. Thromb Haemost 2002; 88: 1060-1065.
11. Leiper J, Vallance P. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovasc Res 1999; 43: 542-548.
12. Dayoub H, Achan V, Adimoolam S, et al. Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence. Circulation 2003; 108: 3042-3047.
13. MacAllister RJ, Parry H, Kimoto M, et al. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br J Pharmacol 1996; 119: 1533-1540.
14. Leiper J, Murray-Rust J, McDonald N, et al. S-nitrosylation of dimethylarginine dimethylaminolrydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginme dimethylanmohydrolase. Proc Natl Acad Sci USA 2002; 99: 13527-13532.
15. Jiang DJ, Jia SJ, Yan J, et al. Involvement of DDAH/ADMA/NOS pathway in nicotine-induced endothelial dysfunction. Biochem Biophys Res Commun 2006; 349: 683-693.
16. Ito A, Tsao PS, Adimoolam S, et al. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 1999; 99: 3092-3095.
17. Chen BM, Xia LW, Zhao RQ. Determination of NG, NG-dimethylarginine in human plasma by high-performance liquid chromatography. J Chromatogr B Biomed Appl 1997; 692: 467-471.
18. Lin KY, Ito A, Asagami T, Tsao, PS, et al. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimedrylaminohydrolase. Circulation 2002; 106: 987-992.
19. Hasegawa K, Wakino, S, Tanaka T, et al. Dimethylarginine dimethylaminohydrolase 2 increases vascular endothelial growth factor expression through Sp1 transcription factor in endothelial cells. Arterioscler Thromb Vasc Biol 2006; 26: 1488-1494.
20. Simeonidis S, Castagliuolo I, Pan A, et al. Regulation of the NK-1 receptor gene expression in human macrophage cells via an NF-kappa B site on its promoter. Proc Natl Acad Sci USA 2003; 100: 2957-2962.
21. Harbrecht BG, Billiar TR, Stadler J, et al. Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical-mediated hepatic injury. J Leukoc Biol 1992; 52: 390-394.
22. Jourdain M, Tournoys A, Leroy X, et al. Effects of Nomega-nitro-Larginine methyl ester on the endotoxin-induced disseminated intravascular coagulation in porcine septic shock. Crit Care Med 1997; 25: 452-459.
23. Shultz PJ, Raij L. Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest 1992; 90: 1718-1725.
24. Westberg G, Shultz PJ, Raij L. Exogenous nitric oxide prevents endotoxin-induced glomerular thrombosis in rats. Kidney Int 1994; 46: 711-716.
25. Vallance P, Leiper J. Cardiovascular biology of the asymmetric dimethylarginine: dimethylarginine dimethylaminohydrolase pathway. Arterioscler Thromb Vasc Biol 2004; 24: 1023-1030.
26. Leiper JM, Santa Maria J, Chubb A, et al. Identification of two human dimethylarginine dimethylamino-hydrolases with distinct tissue distributions and homology with microbial arginine deiminases. Biochem J 1999; 343: 209-214.
27. Jiang DJ, Jiang JL, Tan GS, et al. Protective effects of daviditin A against endothelial damage induced by lysophosphatidylcholine. Naunyn Schmiedebergs Arch Pharmacol 2003; 367; 600-606.
28. Maas R. Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA). Vasc Med 2005; 10 (SuppI 1): S49-57.
29. Niiya Y, Abumiya T, Shichinohe H, et al. Susceptibility of brain microvascular endothelial cells to advanced glycation end products-induced tissue factor upregulation is associated with intracellular reactive oxygen species. Brain Res 2006; 1108: 179-187.
30. Jacobi J, Kristal B, Chezar J, et al. Exogenous superoxide mediates pro-oxidative, proinflammatory, and procoagulatory changes in primary endothelial cell cultures. Free Radic Biol Med 2005; 39: 1238-1248.
31. Chan EL, Murphy JT. Reactive oxygen species mediate endotoxin-induced human dermal endothelial NF-kappaB activation. J Surg Res 2003; 111: 120-126.
32. Böger RH, Bode-Boger SM, Tsao PS, et al. An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes. J Am Coll Cardiol 2000; 36: 2287-2295.
33. Parry GC, Mackman N. Transcriptional regulation of tissue factor expression in human endothelial cells. Arterioscler Thromb Vasc Biol 1995; 15: 612-621.
34. Orthner CL, Rodgers GM, Fitzgerald LA. Pyrrolidine dithiocarbamate abrogates tissue factor (TF) expression by endothelial cells: evidence implicating nuclear factor-kappa B in TF induction by diverse agonists. Blood 1995; 86: 436-443.
35. Mittermayer F, Namiranian K, Pleiner J, et al. Acute Escherichia coli endotoxaemia decreases the plasma 1-arginine/asymmetrical dimethylarginine ratio in humans. Clin Sci (Lond) 2004; 106: 577-581.
36. Nijveldt RJ, Siroen MP, Teerlink T, et al. Gut and liver handling of asymmetric and symmetric dimethylarginine in the rat under basal conditions and during endotoxemia. Liver Int 2004; 24: 510-518.